Unveiling the Network regulatory mechanism of ncRNAs on the Ferroptosis Pathway: Implications for Preeclampsia
Yuan Zhang,Jingjing Zhang,Sirui Chen,Mianxin Li,Jin Yang,Jingsi Tan,Binsheng He,Lemei Zhu
DOI: https://doi.org/10.2147/ijwh.s485653
2024-10-01
International Journal of Women s Health
Abstract:Yuan Zhang, 1, 2, &ast Jingjing Zhang, 3, &ast Sirui Chen, 1 Mianxin Li, 1, 4 Jin Yang, 1, 2 Jingsi Tan, 1 Binsheng He, 1, &ast Lemei Zhu 1, 4, &ast 1 Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha 410219, People's Republic of China; 2 School of Stomatology, Changsha Medical University, Changsha 410219, People's Republic of China; 3 Department of Gynaecology and Obstetrics, Hunan Provincial Maternal and Child Health Hospital, Changsha 410219, People's Republic of China; 4 School of Public Health, Changsha Medical University, Changsha 410219, People's Republic of China &astThese authors contributed equally to this work Correspondence: Binsheng He; Lemei Zhu, Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Leifeng Road 1501, Wangcheng District, Changsha, 410219, Chnia, Tel +86 731– 88602602, Email ; Non-coding RNAs (ncRNAs) are transcripts originating from the genome that do not serve as templates for protein synthesis. They function as epigenetic and translational regulators in various pathophysiological mechanisms, including cell proliferation and apoptosis. The ferroptosis signaling pathway, a novel mode of cell death, participates in numerous pathophysiological processes. Its signaling transmission is both complex and precise, featuring interconnected and interdependent pathways. Recent studies suggest that ncRNAs can finely regulate key genes in the ferroptosis pathway, thus modulating cellular functions, reducing oxidative stress, and maintaining maternal-fetal interface homeostasis. Future strategies targeting the ncRNA/ferroptosis axis may provide new perspectives and potential intervention points for treating preeclampsia. This article clarifies how the ncRNA/ferroptosis axis impacts preeclampsia, revealing how ncRNAs interact with ferroptosis, and pinpointing new molecular targets for the treatment of preeclampsia, thereby providing theoretical support for clinical strategies. Keywords: preeclampsia, non-coding RNAs, ferroptosis, network regulation, treatment strategies Preeclampsia (PE), a frequent and serious hypertensive condition in pregnancy, generally manifests beyond the 20th week of gestation. It presents with newly developed hypertension and proteinuria, and frequently involves dysfunction in various maternal end-organs. 1 Risk factors for PE include age, obesity, diabetes, and a history of hypertension. 2 It is worth mentioning that paternal inheritance also participates in and affects the implantation and vasculogenesis of the fetal placenta, thereby mediating the occurrence and development of PE. 3 PE is the leading cause of death among pregnant women and fetuses, impacting around 2-5% of global pregnancies. Annually, over 70,000 women and 500,000 infants die following a diagnosis of PE. 4,5 Despite extensive international research, the precise mechanisms of PE onset remain elusive. Given the complex pathophysiology of the disease, current preventative measures include using low-dose aspirin to reduce the incidence of PE. Once diagnosed, the definitive treatment for PE involves the delivery of the dysfunctional placenta. 6,7 With advancements in epigenetics, many researchers have discovered that manipulating the ncRNA/ferroptosis axis can regulate the progression of PE. Non-coding RNAs (NcRNAs) are RNA molecules transcribed from the genome and exist in various forms, primarily grouped into two kinds: structural ncRNAs and regulatory ncRNAs. 8 Regulatory ncRNAs, which vary in nucleotide length, are classified into small ncRNAs (sncRNA, 18-200 nt), long ncRNAs (lncRNA, >200 nt), and circular RNAs (circRNA). Additionally, several subclasses of sncRNAs, including microRNA (miRNA), piwi-interacting RNA (piRNA), and tRNA-derived small RNA (tsRNA), exist along with other varieties. 9 Once deemed "junk" transcription products, these RNA molecules are now recognized for their substantial impact on various physiological processes, such as RNA maturation, processing, signal transduction, gene expression, protein functionality, and cellular metabolism. 10 Key ncRNAs, including miRNA, lncRNA, and circRNA, are involved in the development of the placental vascular system and in the invasion, migration, proliferation, and apoptosis of trophoblasts. 11 Furthermore, studies indicate that ncRNAs influence the development and progression of PE by targeting essential signaling molecules in the ferroptosis pathway. 12,13 In recent years, ferroptosis, as a novel form of cell death, -Abstract Truncated-
obstetrics & gynecology